
NYSE:BRO
This summary was created by AI, based on 1 opinions in the last 12 months.
Brown & Brown (BRO) is a significant player in the insurance industry with a market capitalization of $31.6 billion. Despite a year-to-date decline of 9%, the company has demonstrated resilience with a compound annual growth rate (CAGR) of approximately 17% over the past five years, reflecting strong historical returns. The firm has been consistent in growing its sales and earnings at annualized rates of 14.8% and 17.9%, respectively. With strong forward growth estimates and solid fundamentals, the stock is perceived as a good long-term holding. However, it is important to note that the insurance sector may be entering a 'hard market' which could pose risks to profitability. Additionally, the recent $9.8 billion acquisition of Accession Risk highlights the company's ambition to expand its market reach, although the integration process will need to be managed carefully given historical precedents.
Brown & Brown is a American stock, trading under the symbol BRO (previously BRO-N on Stockchase) on the New York Stock Exchange (BRO). It is usually referred to as NYSE:BRO or BRO
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on BRO (previously BRO-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Brown & Brown.
Brown & Brown was recommended as a Top Pick by Brendan Caldwell on 2023-10-02. Read the latest stock experts ratings for Brown & Brown.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Brown & Brown.
Brown & Brown is followed by 7 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-26, Brown & Brown (BRO) stock closed at a price of $64.22.
BRO is a $31.6B insurance name which is down 9% year-to-date, but over the past five years it has a ~17% total return CAGR. It pays a small yield of 0.6%, it has grown its sales and earnings at a 14.8% and 17.9% annualized return, respectively. Forward growth estimates are strong, and its fundamentals are solid. The entire insurance industry is likely heading into a 'hard market', which can negatively impact profits, but for a long-term holding, we continue to like this name.
The acquisition of Accession Risk for $9.8B is a large-scale acquisition, potential expanding its market reach in specialty and wholesale channels. There are some risks on the integration of this acquisition, but it has a successful track record of integrations. We think for a long-term, more defensive holding, we would be comfortable buying here.
Unlock Premium - Try 5i Free